upcarta
  • Sign In
  • Sign Up
  • Explore
  • Search

Ben Derman

No followers
community-curated profile

Asst Professor at University of Chicago, specializing in (vanquishing) plasma cell disorders. I tweet about: Myeloma & MRD. https://linktr.ee/bderman

Overview Content
Featured content
See All
  • Results of ALLO-715, an allogeneic BCMA-targeting CAR T cell therapy are published. Novel features to this product: ‼️ Has rituximab kill switch ‼️ Knockout of the T cell receptor alpha constant (TRAC) to reduce GVHD risk ‼️ Knockout CD52 /1 #mmsm w
    by Ben Derman
  • upcarta ©2025
  • Home
  • About
  • Terms
  • Privacy
  • Cookies
  • @upcarta